Sort
82,697 grants matching “vaccine development”
Phase I I/UCRC Johns Hopkins University Site: Advanced Mammalian Biomanufacturing Innovation Center (AMBIC)
$956,000Michael J Betenbaugh · Johns Hopkins University · · FY2016 · ENG
Basic Research Support for the CCR
$955,878Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
A human monoclonal antibody therapy for treatment of hantavirus cardiopulmonary syndrome
$955,865Joana M Murad · Celdara Medical, Llc · R42 · FY2025 · AI
Preclinical Development of a Recombinant Dengue Vaccine
$955,711Hawaii Biotech, Inc. · U01 · FY2003 · AI
The Effects of COVID-19 on the Well-being, Cognition and Mortality of Persons Living With Dementia
$955,699Michael D Hurd · Rand Corporation · R01 · FY2024 · AG
Center for Translational Pediatric Research
$955,666Alan Jackson Tackett · Arkansas Children'S Hospital Res Inst · P20 · FY2023 · GM
Core D: Clinical Research Core
$955,583Ighovwerha Ofotokun · Emory University · P30 · FY2020 · AI
Optimizing Oral Pediatric HIV Vaccines to Prevent Breast Milk Transmission
$955,475Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2014 · DE
Development of a rapid response nucleic acid vaccine strategy for coronavirus epidemics
$955,395Kenneth C Bagley · Orlance, Inc. · R44 · FY2021 · AI
Transgenic Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture
$955,385Peter F. Billingsley · Sanaria, Inc. · R44 · FY2014 · AI
Advanced Development of a Universal Influenza Vaccine
$955,166Christopher Locher · Versatope Therapeutics, Inc. · N01 · FY2025 · AI
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis
$955,150Jonathan F Lovell · State University Of New York At Buffalo · R33 · FY2025 · AI
Shigella Live Vector-Based Multivalent Vaccine
$955,045Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2014 · AI
Genomic Resource Grant for the PhenX Toolkit - expansion and sustainabilityPhenX Supplement for COVID-19 Research
$955,000Carol M Hamilton · Research Triangle Institute · U41 · FY2020 · HG
Vaccine Research and Development for Endemic, Emerging, and Resurgent Viruses
$955,000Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Enhanced Surveillance for New Vaccine Preventable Diseases
$954,794Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2008 · IP
Baylor College of Medicine Clinical Trial Unit
$954,755William Thomas Shearer · Baylor College Of Medicine · U01 · FY2008 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$954,753Joseph E Robertson · Oregon Health & Science University · P51 · FY2007 · RR
GMP MANUFACTURE OF CLINICAL GRADE THERAPEUTIC VACCINE FOR THE TREATMENT OF PATIENTS WITH CHRONIC HBV
$954,675Valerian Nakaar · Carogen Corporation · R44 · FY2022 · DK
Novel Vaccine Technology for Chikungunya
$954,393Scott C Weaver · University Of Texas Med Br Galveston · R01 · FY2013 · AI
Molecular Biology of Picornavirus Replication
$954,367Elvera Ehrenfeld · Niaid Extramural Activities · Z01 · FY2007 · AI
Innate Control of SIV-Specific Adaptive Immunity
$954,337Bali Pulendran · Emory University · U19 · FY2015 · AI
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation
$954,265Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Phase I Trial of Tuberculosis Vaccine - VTEU
$954,161Patricia Winokur · University Of Iowa · N01 · FY2015 · AI
Structure and Function of Flaviviruses
$953,987Richard J. Kuhn · Purdue University · R01 · FY2017 · AI